Sheiman Ultrasonic Research Foundation

Sheiman Ultrasonic Research Foundation (SURF) is a specialized research organization dedicated to advancing ultrasonic technologies for medical and industrial applications. Founded by Vladimir Sheiman, the foundation focuses on the development of innovative ultrasonic drug delivery systems and non-invasive therapeutic devices. Their core expertise lies in utilizing high-intensity focused ultrasound (HIFU) and acoustic cavitation to enhance the penetration of therapeutic agents into targeted tissues. SURF operates primarily as an intellectual property incubator, holding numerous patents related to ultrasonic transducers and treatment methods. The foundation's work aims to improve clinical outcomes in oncology, cardiovascular medicine, and the treatment of infectious diseases through precise, energy-based interventions.